跳到正文
Elisa Agostinetto· @ElisaAgostinett · X·· 1 天前评分70

#BREASTCANCER

正文 · 原文

At #ESMO26 proffered paper session 1️⃣ on #breastcancer

Final results of B-42 (15-y analysis)

Extended ET (10 vs. 5 years) confirms a modest but significant improvement in DFS, BCFI and DR

Larger benefit in DR for node+

No OS difference

No ⬆️ osteoporotic fx

@OncoAlert

440 浏览 · 12 赞 · 10 转发 · 0 回复

来源:Elisa Agostinetto · x.com

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org